NL-OMON52207
Completed
Phase 4
Recovery of carotid body function after full recovery neuromuscular block - Breath 2 trial
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- perioperatieve verslapping
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age: \>18 years old
Exclusion Criteria
- •BMI index; \>30 kg/m2
- •Known or suspected neuromuscular disorders impairing neuromuscular function;
- •Allergies to muscle relaxants, anesthetics or narcotics;
- •A (family) history of malignant hyperthermia or any other muscle disease;
- •Any neurological or psychiatric illness (including a history of anxiety).
- •ASA class 3 or higher
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
The BREATH 2 trialEUCTR2020-000057-27-NLeiden University Medical Center35
Completed
Phase 4
The Breath-2 TrialPeripheral ChemosensitivityNCT05149872Leiden University Medical Center35
Completed
Not Applicable
Functional imaging after carotid endarterectomy for detection of cerebral hyperperfusion syndromecerebral hyperfusion syndrome after carotid revascularization, measurement of cerebral blood volumeI67.9Cerebrovascular disease, unspecifiedDRKS00026653Siemens Healthcare GmbH45
Recruiting
Not Applicable
Robot-assisted arm therapy and brain stimulation to enhance recovery after strokeACTRN12618001835235Clinical Professor Soumya Ghosh85
Completed
Not Applicable
Reversal of cerebrovascular endothelial dysfunction in diabetes: the effect of allopurinol upon cerebrovascular nitric oxide bioavailabilityISRCTN68849312Greater Glasgow NHS Board/Glasgow University (UK)24